e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.00p
   
  • Change Today:
    -0.15p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 169,640
  • Market Cap: £64.28m

e-Therapeutics Overview

e-Therapeutics is in the pharma and biotech sector and is currently trading at 11.00p per share. In the last year e-Therapeutics's share price has ranged from 8.13p to 23.10p.

1 Day Chart (28-03-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2155.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 135.3 142.9
Pr/Book 1.9  
Latest F'cast
Revenue -0.4% 5.3%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

e-Therapeutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-19 0.04 (5.09) (1.49)p n/a n/a n/a n/a 0.0%
31-Jan-20 0.46 (2.87) (0.87)p n/a n/a n/a n/a 0.0%
31-Jan-21 0.32 (4.47) (0.99)p n/a n/a n/a n/a 0.0%
31-Jan-22 0.48 (9.52) (1.65)p n/a n/a n/a n/a 0.0%
31-Jan-23 0.47 (9.77) (1.54)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

e-Therapeutics Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-24 0.50 n/a (1.54)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

e-Therapeutics Company Announcements

Total Voting Rights 31-Jan-2024 16:30 RNS
Exercise of Options and Issue of Equity 24-Jan-2024 10:04 RNS
Business Update 16-Jan-2024 07:00 RNS

Latest e-Therapeutics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 11.00p
Change Today -0.15p
% Change -1.35 %
52 Week High 23.10
52 Week Low 8.13
Volume 169,640
Shares Issued 584.34m
Market Cap £64.28m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.91% below the market average27.91% below the market average27.91% below the market average27.91% below the market average27.91% below the market average
48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average
Price Trend
59.31% below the market average59.31% below the market average59.31% below the market average59.31% below the market average59.31% below the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Income Not Available
Growth
15.52% below the market average15.52% below the market average15.52% below the market average15.52% below the market average15.52% below the market average
18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 21 @ 11.00p
16:35 2 @ 11.00p
16:35 19 @ 11.00p
16:29 9 @ 10.80p
16:29 9 @ 11.00p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page